ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.87%
      US Tech 100
      16,783.20
      0.18%
      Dow Jones
      38,239.98
      0.67%
      Brent Oil
      87.035
      0.72%
      Bitcoin
      66,076.39
      -1.17%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bio Techne Corporation (TECH)

      7. Bio Techne Corporation (TECH) News

      TECH Bio Techne Corporation

      62.80
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:00:14
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Bio Techne Corporation TECH NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 62.80 04:00:14
      Open Price Low Price High Price Close Price Prev Close
      62.80
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      4/10/202407:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO..
      4/08/202407:00PRNUSBIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS..
      4/03/202407:00PRNUSBIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR..
      4/01/202407:00PRNUSBIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR..
      3/28/202409:00PRNUSBIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP..
      3/22/202407:00PRNUSBIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR..
      3/12/202407:00PRNUSBIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH..
      3/11/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202415:03EDGAR2Form 144 - Report of proposed sale of securities
      3/06/202407:00PRNUSBIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL..
      2/07/202416:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      2/05/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/05/202418:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/05/202418:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
      2/05/202418:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/01/202406:30PRNUSBIO-TECHNE DECLARES DIVIDEND
      1/29/202407:00PRNUSBIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW..
      1/25/202407:00PRNUSLUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH..
      1/24/202407:00PRNUSSCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN..
      1/16/202407:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO..
      1/08/202406:32EDGAR2Form 8-K - Current report
      1/05/202407:00PRNUSBIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS..
      1/04/202407:00PRNUSBIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING..
      12/21/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/21/202307:00PRNUSBIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN..
      12/20/202307:00PRNUSBIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR..
      12/14/202318:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
      12/14/202307:00PRNUSLUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP..
      11/27/202307:00PRNUSBIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI..
      11/13/202307:00PRNUSBIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
      11/07/202316:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/03/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/03/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/03/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/02/202307:00PRNUSASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023..
      10/31/202306:30EDGAR2Form 8-K - Current report
      10/31/202306:30PRNUSBIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
      10/30/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202316:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/25/202309:00PRNUSLEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING..
      10/19/202307:00EDGAR2Form 8-K - Current report
      10/19/202307:00PRNUSBIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
      10/16/202307:00PRNUSBIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS..
      10/10/202307:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO..

      Your Recent History

      NASDAQ
      TECH
      Bio Techne
      Delayed Upgrade Clock